SNEE Covid-19 Oral Antiviral Treatment Service

  • NHS Suffolk and North East Essex ICB

F14: Notice for changes or additional information

Notice identifier: 2024/S 000-022615

Procurement identifier (OCID): ocds-h6vhtk-047bf0

Published 22 July 2024, 10:07am



Section one: Contracting authority/entity

one.1) Name and addresses

NHS Suffolk and North East Essex ICB

Aspen House, Stephenson Road,Severalls Business Park

COLCHESTER

CO49QR

Contact

Sarah Skilton

Email

sarah.skilton@snee.nhs.uk

Telephone

+44 1473770225

Country

United Kingdom

Region code

UKH34 - Essex Haven Gateway

NHS Organisation Data Service

QJG

Internet address(es)

Main address

https://suffolkandnortheastessex.icb.nhs.uk/

Buyer's address

https://in-tendhost.co.uk/snee-icb/aspx/Home


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

SNEE Covid-19 Oral Antiviral Treatment Service

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

The aim of this service is to provide the clinical infrastructure to support the safe, timely and appropriate dispensing of antiviral medication for the treatment of Covid-19 for non-hospitalised patients across Suffolk and North East Essex. The service is designed to ensure choice and prompt access to these medicines in the community setting for eligible patients when they are required at all times whilst the pharmacies are open. Each provider will stock a minimum of THREE packs of each antiviral medication (or higher based on local demand) and will make a commitment to ensure eligible patients have prompt access to these medicines to facilitate treatment within 5 days of the onset of symptoms. Patients will receive a full clinical review by a SNEE Covid Management Delivery Unit (CMDU) prescriber and if eligible for treatment, an EPS prescription will be sent to the commissioned community pharmacy, in line with the consent and choice of the patient.

Pharmacists will contact the patient as soon as possible upon receipt of the prescription to confirm consent and clinical suitability for treatment. This discussion is recorded on an electronic platform confirming all checks have been performed to confirm appropriateness of treatment. As appropriate, the pharmacy will make arrangement with the patient/carer for the medication to be collected or delivered.


Section six. Complementary information

six.6) Original notice reference

Notice number: 2024/S 000-020928


Section seven. Changes

seven.1) Information to be changed or added

seven.2) Other additional information

This is a Provider Selection Regime (PSR) confirmation of contract award notice.

This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contract Regulations 2015 do not apply to this award.

This contract has now been formally awarded using direct award process C.

Contract award date: 27/06/2024

The dates between which the services are intended to be provided are: 27/06/2024 to 31/03/2025

Lifetime value of the contract is anticipated to be: Value excluding VAT: £8550.00

There was no review during the standstill period.